Search results for PX-TA1053
Showing 1 – 10 of1products

ID: BAB118411395
Natalizumab Biosimilar – Anti-ITGA4, CD49d mAb – Research Grade, ProteoGenix, PX-TA1053
Description of Natalizumab Biosimilar - Anti-ITGA4, CD49d mAb - Research Grade General information on Anti-ITGA4/CD49d(Homo sapiens) (Natalizumab) Monoclonal Antibody Natalizumab is a humanized monoclonal antibody produced in murine myeloma cells of isotype IgG4k. Natalizumab contains a human framework region and a complementarity determining region of a murine antibody that binds to alpha 4-integrin. Natalizumab has been temporarily discontinued due to the risk of progressive multifocal leukoencephalopathy (PML).
Host
Reactivity
Applications
Conjugation
Request a product
Please provide the required information below so that we can quickly source your products.
